Clinical Trials Logo

Filter by:
NCT ID: NCT01388244 Completed - Osteoporosis Clinical Trials

Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)

ROSE
Start date: February 2010
Phase: N/A
Study type: Interventional

The Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE) is a randomised population-based study, including 20,904 Danish women aged 65-80 years, investigating the effectiveness of a two-step screening programme for osteoporosis, using a questionnaire based on FRAX® followed by DXA-scan of those at highest risk. Further, the study is expected to provide knowledge about cost-effectiveness, patient preferences and acceptance of screening programme to prevent fractures

NCT ID: NCT01388088 Completed - Hypertension Clinical Trials

The Effect of Amiloride and Spironolactone in Patients With Hypertension

hass
Start date: September 2010
Phase: Phase 4
Study type: Interventional

The investigators wish to investigate the potential effects of potassium. In this study we will examine patients with hypertension and increase their potassium-levels using Amiloride and Spironolactone. The investigators will examine the changes in the cardiovascular system using a Sphygmocor-scanner.

NCT ID: NCT01387880 Completed - Clinical trials for Metastatic Colorectal Cancer

Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer

ICE
Start date: January 2010
Phase: Phase 2
Study type: Interventional

This is an open, multicenter phase II trial of therapy with a combination of cetuximab, and irinotecan every second week combined with a daily dose of everolimus to patients with metastatic colorectal cancer with Kirsten rat sarcoma viral oncogene (KRAS) mutation or to patients resistent to cetuximab and irinotecan therapy for metastatic colorectal cancer.

NCT ID: NCT01387867 Completed - Hip Osteoarthritis Clinical Trials

Exercise in Patients With Osteoarthritis of the Hip

Start date: October 2009
Phase: N/A
Study type: Interventional

According to Danish and international guidelines the recommended first-line of management for people with osteoarthritis consist of exercise, education, analgesic medication, and, if necessary, weight reduction. It is well documented that exercise has a positive effect on pain and physical function in patients with knee OA, but the effect of exercise on hip OA is sparsely investigated. Aim of the study: To investigate the effects of 1) strength training, and 2) Nordic Walking, and 3) unsupervised home based exercise on muscle function, endurance, pain level, physical activity, and health related quality of life in patients with osteoarthritis of the hip. The effects of exercise on muscle mass and the mechanisms behind the osteoarthritis, i.e., disease activity, inflammation, and cartilage degradation, are investigated in a subgroup (n=45) of the participants. Study hypotheses: Strength training will have a greater effect on physical function and muscle strength than Nordic Walking and home based exercise; 2) Nordic Walking will have a greater effect on endurance than strength training and unsupervised home based exercise; 3) Strength training and Nordic Walking will have a greater effect on pain level and health related quality of life than unsupervised home based exercise.

NCT ID: NCT01387763 Completed - Clinical trials for Primary Myelofibrosis

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms

DALIAH
Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy and toxicity including quality of life of two types of low-dose interferon alpha compounds (PegIntron and Pegasys) with hydroxyurea (Hydrea), and to investigate the occurence of neutralizing antibodies against recombinant interferon.

NCT ID: NCT01387373 Completed - Clinical trials for Metastatic Breast Cancer

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This is a phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic capecitabine and in patients with a HER2-positive tumour in combination with trastuzumab (Herceptin®) in patient with non-resectable liver metastases from breast cancer. Only patients without extrahepatic disease are included.

NCT ID: NCT01387295 Completed - Clinical trials for Metastatic Breast Cancer

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This is a phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic capecitabine and in patients with a HER2-positive tumour in combination with trastuzumab (Herceptin®) in patient with non-resectable liver metastases from breast cancer. Only patients with limited extrahepatic disease are included.

NCT ID: NCT01386164 Completed - HIV Clinical Trials

Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults

HIPAVAC
Start date: August 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to analyze and compare the immunogenicity of Bivalent and Tetravalent vaccines against Human Papillomavirus in HIV-infected adult persons.

NCT ID: NCT01385631 Completed - Clinical trials for ST-Segment Elevation Myocardial Infarction

Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.

OCTIVUS
Start date: June 2011
Phase: Phase 4
Study type: Interventional

The purpose of the study is to examine the effect of the cholesterol lowering agent Ezetimibe when used in addition to optimal treatment with Atorvastatin in patients with acute ST-Elevation Myocardial Infarction (STEMI) who have not been in prior statin therapy. An area with arteriosclerosis not demanding intervention in a coronary vessel other than the infarct related is used as measuring point and is examined at time of the infarction and after 12 month using intravascular ultrasound and optical coherence tomography. At the same time the same techniques are used to examine the implanted stent.

NCT ID: NCT01384812 Completed - Clinical trials for Migraine-like Headache

Prostaglandin E2 in Migraine Suffers Without Aura.

Start date: September 2010
Phase: N/A
Study type: Interventional

The hypothesis of this study is that Prostaglandin E2 (PGE2) induces headache and dilatation of brain vessels in migraine patients without aura.